Milne RW - Search Results

1

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

Bain MA, Faull R, Fornasini G, Milne RW, Evans AM. Bain MA, et al. Among authors: milne rw. Nephrol Dial Transplant. 2006 May;21(5):1300-4. doi: 10.1093/ndt/gfk056. Epub 2006 Jan 9. Nephrol Dial Transplant. 2006. PMID: 16401621

2

Oral L-carnitine: metabolite formation and hemodialysis.

Bain MA, Faull R, Milne RW, Evans AM. Bain MA, et al. Among authors: milne rw. Curr Drug Metab. 2006 Oct;7(7):811-6. doi: 10.2174/138920006778520561. Curr Drug Metab. 2006. PMID: 17073580 Clinical Trial.

3

Quantifying trimethylamine and trimethylamine-N-oxide in human plasma: interference from endogenous quaternary ammonium compounds.

Bain MA, Faull R, Fornasini G, Milne RW, Schumann R, Evans AM. Bain MA, et al. Among authors: milne rw. Anal Biochem. 2004 Nov 15;334(2):403-5. doi: 10.1016/j.ab.2004.07.004. Anal Biochem. 2004. PMID: 15494149 No abstract available.

4

Disposition and metabolite kinetics of oral L-carnitine in humans.

Bain MA, Milne RW, Evans AM. Bain MA, et al. Among authors: milne rw. J Clin Pharmacol. 2006 Oct;46(10):1163-70. doi: 10.1177/0091270006292851. J Clin Pharmacol. 2006. PMID: 16988205 Clinical Trial.

5

The effects of phytoestrogenic isoflavones on the formation and disposition of paracetamol sulfate in the isolated perfused rat liver.

Lucas AN, Nation RL, Milne RW, Reynolds GD, Evans AM. Lucas AN, et al. Among authors: milne rw. J Pharm Pharmacol. 2003 May;55(5):639-46. doi: 10.1211/002235703765344540. J Pharm Pharmacol. 2003. PMID: 12831506

6

Loading-washout studies of the stereoselective sinusoidal uptake of (R)- and (s)-2-phenylpropionyl acyl glucuronide.

Shackleford DM, Evans AM, Milne RW, Nation RL. Shackleford DM, et al. Among authors: milne rw. Curr Drug Metab. 2006 Oct;7(7):817-26. doi: 10.2174/138920006778520589. Curr Drug Metab. 2006. PMID: 17073581

7

The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay.

Jensen LS, Valentine J, Milne RW, Evans AM. Jensen LS, et al. Among authors: milne rw. J Pharm Biomed Anal. 2004 Feb 18;34(3):585-93. doi: 10.1016/s0731-7085(03)00573-9. J Pharm Biomed Anal. 2004. PMID: 15127815

8

The effects of the phytoestrogenic isoflavone genistein on the hepatic disposition of preformed and hepatically generated gemfibrozil 1-O-acyl glucuronide in the isolated perfused rat liver.

Lucas AN, Brogan LR, Nation RL, Milne RW, Evans AM, Shackleford DM. Lucas AN, et al. Among authors: milne rw. J Pharm Pharmacol. 2003 Oct;55(10):1433-9. doi: 10.1211/0022357022016. J Pharm Pharmacol. 2003. PMID: 14607027

9

Inhibition of morphine metabolism by ketamine.

Qi X, Evans AM, Wang J, Miners JO, Upton RN, Milne RW. Qi X, et al. Among authors: milne rw. Drug Metab Dispos. 2010 May;38(5):728-31. doi: 10.1124/dmd.109.030957. Epub 2010 Feb 2. Drug Metab Dispos. 2010. PMID: 20124399

10

Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.

Milne RW, Jensen RH, Larsen C, Evans AM, Nation RL. Milne RW, et al. Pharm Res. 1997 Aug;14(8):1014-8. doi: 10.1023/a:1012145126847. Pharm Res. 1997. PMID: 9279882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page